CooperVision, Inc.

CooperVision is a global leader in soft contact lens manufacturing and distribution, serving over 130 countries with innovations in vision correction. The company manufactures and markets a comprehensive portfolio of daily disposable, 2-week, and monthly replacement soft contact lenses for spherical, toric (astigmatism), and multifocal (presbyopia) corrections. Key product families include MyDay® daily disposables (including MyDay Energys® for digital eye strain), clariti® 1 day (budget-friendly option), MiSight® 1 day (FDA-approved for pediatric myopia control), Biofinity® monthly lenses (premium comfort), and Avaira Vitality® 2-week lenses. CooperVision utilizes silicone hydrogel and hydrogel material technologies, with features such as UV blockers and lipid-corralling technology for extended wear comfort. The company holds FDA approval for MiSight® 1 day for myopia control in children ages 8–12, and markets lenses with claimed advantages in breathability, comfort, visual clarity, and ease of handling. CooperVision operates as part of CooperCompanies and serves millions of contact lens wearers globally through eye care professionals, optometrists, and ophthalmologists. The company emphasizes innovation in contact lens design, material science, and myopia management solutions for the consumer vision care market.